News
The Trump administration is contemplating a pilot program to cover weight-loss drugs under Medicare and Medicaid. The ...
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
Shares in Novo Nordisk fell as much as six per cent on Friday to their lowest since August 2021, extending recent losses to ...
36mon MSN
US plans to test Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback